Trial Profile
A study to evaluate myelin oligodendrocyte glycoprotein transduced T cells in multiple sclerosis
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2017
Price :
$35
*
At a glance
- Drugs MOG transduced T cells ImCyse (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 24 Aug 2017 New trial record